Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Jeffrey Lebensburger, MD
Healthcare Provider Director of Pediatric Hematology Section
UAB Division of Hematology and Oncology
Children's of Alabama
1600 7th Ave. S.
Lowder Bldg., Suite 512
Birmingham, Alabama, United States
Dr. Lebensburger is a graduate of the University of Pennsylvania for undergraduate training and the Nova Southeastern Medical School. After his pediatric residency at Arnold Palmer Hospital for Children in Orlando, Florida, Dr. Lebensburger completed fellowship training in Pediatric Hematology Oncology at St. Jude Children’s Research Hospital. His primary clinical focus involves caring for children with blood disorders, including sickle cell disease, thalassemia, bleeding disorders, disorders of iron metabolism, and marrow failure syndromes.
In addition to his clinical care, Dr. Lebensburger focuses on linking knowledge from basic science to clinical care (translational research) especially in sickle cell disease. Currently, Dr. Lebensburger is the primary investigator for two prestigious research grants from the National Institutes of Health and American Society of Hematology to better understand kidney disease in patients with sickle cell disease. While pain is the hallmark clinical complication of sickle cell disease, many young adult patients suffer from early development of kidney failure.
Representative Publications:
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia
Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis
Hydroxycarbamide for patients with silent cerebral infarcts: outcomes and patient preference
Elective cholecystectomy reduces morbidity of cholelithiasis in pediatric sickle cell disease
Related Content
-
Monica Hulbert, MDDr. Hulbert is the Director of the Sickl...
-
Virginia Commonwealth University, Massey Cancer CenterVCU Massey Cancer Center is among the to...
-
The Sickle Cell & Hemoglobinopathy Center of Western New YorkThe Sickle Cell & Hemoglobinopathy C...
-
Decreased hospital readmissions for vaso occlusive crisis with implementation of a Sickle Cell Pain Action Plan (SPA...Vaso occlusive crisis (VOC) is the most ...
-
Outcomes of an Emergency Department Observation Unit–Based Pathway for the Treatment of Uncomplicated Vaso-Occlusi...Study objective: This was a prospective...
-
Marilyn Telen, MDDr. Telen is the Associate Professor of ...
-
Why do blood types matter? – Natalie S. Hodgehttps://www.youtube.com/watch?v=xfZhb6lm...